showed that overexpression of kallistatin in an in vivo model ameliorates diabetes‐induced retinal leukostasis and vascular leakage, by inhibiting diabetes‐induced Wnt/β‐catenin signalling pathway activation (Liu et al., 2013). Here, SERPINA4 is linked to diabetes mellitus.